Tag: antidepressants

Alicia Martin is an Australian community pharmacist and the creator of an ingenious mobile app, TaperMate, which aims to help people with hyperbolic drug tapering and prescribed drug withdrawal.

For almost 40 years, psychiatric leaders have denied that antidepressants increase suicides despite overwhelming evidence.

Science is supposed to be self-correcting. But what happens when the journals entrusted to uphold this principle become its gatekeepers?

We must warn about the harms of antidepressants and bring people to justice who contribute to the suicides and homicides by lies and medical malpractice.

This week Mad in America examines three studies related to adverse effects of antidepressants. The first study finds that antidepressant use is linked to...

Physician-anthropologist Khameer Kidia examines how violence and inequality shape mental distress, arguing for patient autonomy, community care, and structural change beyond diagnosis, medication, and individualized psychiatric treatment.

From Substack, written by Bryan Shapiro MD. "The following is a rapid-fire, scientific rebuttal of the recent psychiatric times article “The Top 10 Misleading...

The approval is an example of what can go wrong in "evidence-based" psychiatry due to conflicts of interest and placing guild interests before patient safety.

Genetic testing to guide antidepressant selection is already being sold to the public, but the evidence is less than convincing. A new study failed to show efficacy in its primary outcome, its secondary outcomes imply a potential benefit for only 2% of patients, and it contradicts the findings of a previous study, leaving interpretation uncertain.

Past research has framed symptom increases during tapering and discontinuation of psychotropic drugs as a relapse of an underlying “illness.” A new preprint article...

This week Mad in America examines three studies related to the adverse effects of psychotropic drugs and one that investigates the effect of keto...

This week Mad in America explores four recently published articles related to antidepressant use in children and adolescents. The first reports that although clinical...

Agnes Higgins and Cathal Cadogan join us to discuss their work on understanding the experiences of people tapering from psychiatric medication and the role that pharmacists could potentially play when people are considering stopping their psychiatric drugs.

SSRI antidepressants have been linked to a number of adverse effects. A recent study presents evidence that a new condition may need to be...

This week Mad in America examines studies related to adverse events associated with antipsychotics and antidepressants, including two studies that found increased risk of...

The idea that the FDA black box warning led to increased suicide is just as easily refuted by the data now as when it was first proposed.

This week, Mad in America examines recent antidepressant research questioning withdrawal severity, a study of unsupported biological beliefs about mental "illness," and research linking...

Response and remission rates failed to beat placebo in a new Harvard meta-analysis, throwing the inflammation hypothesis into question.

Psychiatric drugs linked to increased risk of the rare, incurable neurological disease that causes loss of motor function.

Researchers found that for many doctors, renewing antidepressant prescriptions feels safer and faster than helping people taper, and that most current interventions fail to address the pressures driving that choice.

A new study in Health Expectations led by Trinity College Dublin researchers finds that people withdrawing from psychiatric medications often endure severe symptoms, limited clinical support, and widespread uncertainty about how to taper safely.

The Wall Street Journal is reporting on the overprescribing of psychiatric drugs in America. They would like to hear about your experiences and any...

It is right to criticize MAHA, but poorly researched, fear-based responses by mainstream psychiatry only further mislead the public.

The authors call for a paradigm shift in mental health care that emphasizes empathy, context, and alternatives to medication as first-line treatments for depression.

New research from Germany shows how guidelines, system pressures, and lack of collaboration limit deprescribing.